Background and Purpose-Animal models suggest a genetic contribution to cerebral susceptibility to ischemia. Family history of stroke (FHx stroke ) is a risk factor for ischemic stroke, but there is significant confounding by heritability of hypertension and other intermediate phenotypes, and it is uncertain whether genetic factors have a direct independent influence on cerebral susceptibility to ischemia in man. Methods-We related detailed FHx stroke to baseline characteristics and subsequent risk of stroke in 2 population-based incidence studies and a consecutive hospital-referred series of patients with recent transient ischemic attack (TIA 
A nimal models and twin studies suggest that genes influence susceptibility to ischemic stroke, and there are some rare Mendelian stroke syndromes, as well as evidence of heritability of sporadic ischemic stroke in man. 1, 2 Genetic factors could influence susceptibility to stroke through intermediate phenotypes, such as hypertension and atherosclerosis, 3 but might also influence cerebral susceptibility to ischemia (ie, for a given ischemic insult, the extent of brain injury could vary). Animal models show evidence of genetic variation in cerebral susceptibility to ischemia, 4, 5 but there is as yet little evidence in man.
Follow-up of transient ischemic attack (TIA) patients might provide insight into cerebral susceptibility to ischemia in man. First, the risk of stroke is high, 6 allowing detailed clinical studies with sufficient statistical power. Second, the prospective design avoids the recall bias inherent in casecontrol studies. Third, biases attributable to missing data in patients with severe stroke are avoided, and potential confounding factors (eg, blood pressure, glucose) are measured more reliably. Fourth, because most TIA patients have vascular pathology, confounding by intermediate phenotypes should be reduced, allowing more reliable determination of factors that directly influence cerebral susceptibility. Yet, there has been only 1 study of the predictive value of family history of stroke (FHx stroke ) in TIA patients. 7 We therefore studied detailed FHx stroke in 2 population-based TIA cohorts 8, 9 and a consecutive hospital-referred series. 10 
Methods
The methods of all 3 cohorts have been published previously. 6,8 -11 Briefly, the Oxfordshire Community Stroke Project (OCSP) studied the incidence, risk factors, and outcome of incident TIA during 1981 to 1986. 6 The ongoing Oxford Vascular Study (OXVASC) uses identical methods of ascertainment to the OCSP. 8, 9 For this report, we included patients with any TIA without previous stroke during 2002 to 2004. 8 The Oxford hospital-referred TIA series was a consecutive prospective cohort of patients with incident TIA assembled during 1976 to 1986. 10 We calculated odds ratios (ORs) within individual studies and combined them by fixed-effects Mantel-Haenszel meta-analysis. Heterogeneity between studies was calculated with the 2 method. Where appropriate, data were pooled. To study differences in baseline characteristics, we used the 2 test for categorical variables and ANOVA for continuous variables. For any factor that showed an association with FHx stroke , we performed a logistic regression analysis, adjusting for age, sex, and study. ORs conferred by FHx stroke were calculated by multivariate binary regression analysis adjusting for study, age, sex, treated hypertension, cerebral versus ocular TIA, diabetes, atrial fibrillation, smoking, and baseline systolic and diastolic blood pressure. We reassessed antithrombotic drug use, blood pressure, and blood lipids at follow-up to test for possible bias attributable to differential treatment or control of risk factors in relation to FHx stroke .
Results
Of 209 TIA patients in OCSP and 175 in OXVASC, FHx stroke was available in 202 (96.7%) and 164 (93.7%), respectively. Of 469 patients from the hospital-referred series, FHx stroke was available in 391 after exclusion of patients coenrolled in the OCSP. Baseline characteristics are given in Table 1 . FHx stroke was most common in women (Pϭ0.013), in patients with treated hypertension (Pϭ0.003), and with cerebral TIA (Pϭ0.06). Subsequent analyses are thus adjusted for these differences or stratified appropriately. The proportions of patients with any ischemic lesion on computed tomography (CT) and the proportion with a lesion compatible with the presenting symptoms were unrelated to FHx stroke .
A total of 200 (26%) patients had an ischemic stroke, and 126 (17%) had a myocardial infarction (MI) during 5515 patient years of follow-up (OCSP 1411; OXVASC 201; hospital-referred series 3903). FHx stroke did not predict ischemic stroke in any cohort ( Figure) or the pooled analysis (OR stratified by study, 0.97; 95% CI, 0.65 to 1.45; Pϭ0.88; multivariate adjusted OR, 0.86; 0.57 to 1.31; Pϭ0.48). No association was found in subgroup analysis by age (10-year bands), sex, history of hypertension, systolic blood pressure, ocular versus cerebral TIA, and whether parents or siblings were affected, and there was no clear increase in risk in patients with Ͼ1 affected first-degree relatives (FDRs) versus the remainder (adjusted OR, 1.26; 0.56 to 2.83; Pϭ0.57; nϭ32). There was no association between age of affected FDRs at their stroke (meanϭ74 years) and risk of stroke in the proband (Pϭ0.72) and no evidence that FHx stroke increased the risk of stroke in the first 90 days (adjusted OR, 0.56; 0.28 to 1.09; Pϭ0.09). In none of the studies or the pooled data (adjusted OR, 1.35; 0.84 to 2.17; Pϭ0.21) was FHx stroke related to the risk of MI (Figure) .
There was no evidence that patients with FHx stroke received more aggressive preventive treatment or had better control of blood pressure during follow-up (Tables 1 and 2 ).
Discussion
In patients with a recent TIA, FHx stroke correlated with treated hypertension but did not predict appropriately located ischemic lesions on cerebral CT or the risk of subsequent stroke. These results will be useful in counseling TIA patients and show that risk of ischemic stroke after TIA is not highly heritable.
A study of heritability of stroke after TIA has the advantages outlined in the introduction, but our study does have some potential shortcomings. First, patient-reported FHx stroke is sometimes inaccurate. Nevertheless, it has good discriminatory power. 12 Second, in common with previous studies, we had no information on the stroke subtype in the FDRs. Studies of affected sib-pairs enable detailed examination of relatives, but it would be difficult to assemble a large enough cohort of sib-pairs with TIA to study cerebral susceptibility. We were also unable to stratify results by underlying etiological subtype in the proband. 13 However, our observations suggest that any effects in specific subtypes are unlikely to be large. Third, it is possible that the presence of FHx stroke increased the likelihood of diagnosis of TIA. However, diagnoses were made by vascular neurologists according to strict criteria, and the proportion of patients with appropriately located lesions on CT was unrelated to FHx stroke . Fourth, factors determining susceptibility to TIA might be similar to those for susceptibility to stroke, and we have not studied the hypothetical group of individuals who do not have a TIA despite having microemboli. Fifth, the included studies varied in the available length of follow-up. Also, whereas the population-based studies included the high-risk period of stroke immediately after a TIA, this period was not covered by the hospital-based cohort, explaining the different rates of strokes between the studies. However, our results were highly consistent in all 3 studies, and there was also no significant difference between early and late strokes.
